Ruby Abrams

Background

About Ruby Abrams

At C-Path, our team focuses on the transformative power of Digital Health Technologies (DHTs) to advance patient care. Leading efforts in this dynamic field, we've developed a framework for activity identification and verification, crucial for mobility assessments in neurodegenerative diseases. This innovation aids drug developers in creating clinically relevant metrics and supports device companies by ensuring the reliability of their algorithms. My applied mathematics background, bolstered by proficiency in Git and software development, is core to our success. By infusing mechanistic and machine learning algorithms into our research, we provide comprehensive verification and validation evidence. This meticulous approach not only enhances drug development processes but also upholds the safety and efficacy standards necessary for regulatory approval.